Racial Disparities in Breast Cancer Mortality are Not Driven by Estrogen Receptor Status Alone – 3
Narrator: This is NIH Health Matters.
Menashe: The goal of our study was to explore the underlying causes of the black/white racial disparity in breast cancer mortality in the U.S.
Narrator: Dr. Idan Menashe is with the National Cancer Institute and is lead author of the study.
Menashe: We employed different statistical analysis, but particularly we used a statistical approach called an incidence based mortality that allows us to examine the mortality rate according to specific tumor characteristics, for example the differences in ER status.
Narrator: ER stands for estrogen receptor. And ER negative tumors are more aggressive and more difficult to treat. Menashe adds that black women have a higher prevalence of ER negative tumors. For details on the study, visit www.cancer.gov. Health Matters is produced by the National Institutes of Health, part of the US Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.